Magnetic resonance imaging of tumor necrosis

Acta Oncologica

Volumn 50, Issue 3, 2011, Pages 427-434

  Egeland, Tormod A M ^a   Gaustad, Jon Vidar ^a   Galappathi, Kanthi ^a   Rofstad, Einar K ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG DISTRIBUTION; FEMALE; HUMAN; HUMAN CELL; IMAGE ANALYSIS; MAXIMUM PLASMA CONCENTRATION; MELANOMA CELL; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; TUMOR CELL LINE; TUMOR NECROSIS; TUMOR XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MELANOMA; MICE; MICE, INBRED BALB C; MICE, NUDE; NECROSIS; NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SKIN NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS;

EID: 79952675402     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2010.526633     Document Type: Article

References (27)

1. Jain RK. Determinants of tumor blood flow: A review. Cancer Res 1988;48:2641-58.
2. Steel GG. Growth kinetics of tumors. Oxford UK: Clarendon Press; 1977.
3. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review. Cancer Res 1989;49:6449-65. (Pubitemid 20008770)
4. Fenton BM, Kiani MF, Siemann DW. Should direct measurements of tumor oxygenation relate to the radiobiological hypoxic fraction of a tumor? Int J Radiat Oncol Biol Phys 1995;33:365-73.
5. Verheij M. Clinical biomarkers and imaging for radiotherapy- induced cell death. Cancer Metastasis Rev 2008;27: 471-80.
6. Toms AP, White LM, Kandel R, Bleakney RR, Noseworthy M, Lee S, et al. Limitations of single slice dynamic contrast enhanced MR in pharmacokinetic modeling of bone sarcomas. Acta Radiol 2009;50:512-20.
7. Jakobsen I, Kaalhus O, Lyng H, Rofstad EK. Detection of necrosis in human tumour xenografts by proton magnetic resonance imaging. Br J Cancer 1995;71:456-61.
8. Vossen JA, Buijs M, Geschwind JF, Liapi E, Prieto V, Lee KH, et al. Diffusion-weighted and Gd-EOB-DTPAcontrast- enhanced magnetic resonance imaging for characterization of tumor necrosis in an animal model. J Comput Assist Tomogr 2009;33:626-30.
9. Kettelhack C, Wickede M, Vogl T, Schneider U, Hohenberger P. 31 Phosphorus-magnetic resonance spectroscopy to assess histologic tumor response noninvasively after isolated limb perfusion for soft tissue tumors. Cancer 2002;94:1557-64. (Pubitemid 34212651)
10. Bremer C, Bankert J, Filler T, Ebert W, Tombach B, Reimer P. High-dose Gd-DTPA vs. Bis-Gd-mesoporphyrin for monitoring laser-induced tissue necrosis. J Magn Reson Imaging 2005;21:801-8. (Pubitemid 40770873)
11. Metz S, Daldrup-Unk HE, Richter T, Rät h C, Ebert W, Settles M, et al. Detection and quantification of breast tumor necrosis with MR imaging: Value of the necrosis-avid contrast agent Gadophrin-3. Acad Radiol 2003;10:484-90. (Pubitemid 36534889)
12. Benjaminsen IC, Graff BA, Brurberg KG, Rofstad EK. Assessment of tumor blood perfusion by high-resolution dynamic contrast-enhanced MRI: A preclinical study of human melanoma xenografts. Magn Reson Med 2004;52: 269-76. (Pubitemid 39025270)
13. Graff BA, Benjaminsen IC, Brurberg KG, Ruud EBM, Rofstad EK. Comparison of tumor blood perfusion assessed by dynamic contrast-enhanced MRI with tumor blood supply assessed by invasive imaging. J Magn Reson Imaging 2005;21:272-81. (Pubitemid 40280122)
14. Vestvik IK, Egeland TA, Gaustad JV, Mathiesen B, Rofstad EK. Assessment of microvascular density, extracellular volume fraction, and radiobiological hypoxia in human melanoma xenografts by dynamic contrast-enhanced MRI. J Magn Reson Imaging 2007;26:1033-42. (Pubitemid 47548165)
15. Benjaminsen IC, Brurberg KG, Ruud EBM, Rofstad EK. Assessment of extravascular extracellular space fraction in human melanoma xenografts by DCE-MRI and kinetic modeling. Magn Reson Imaging 2008;26:160-70.
16. Egeland TAM, Simonsen TG, Gaustad JV, Gulliksrud K, Ellingsen C, Rofstad EK. Dynamic contrast-enhanced magnetic resonance imaging of tumors: Preclinical validation of parametric images. Radiat Res 2009;172:339-47.
17. Egeland TAM, Gaustad JV, Benjaminsen IC, Hedalen K, Mathiesen B, Rofstad EK. Assessment of fraction of hypoxic cells in human tumor xenografts with necrotic regions by dynamic contrast-enhanced MRI. Radiat Res 2008;169:689-99. (Pubitemid 351793458)
18. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, et al. Estimating kinetic parameters from dynamic contrast-enhanced T 1 -weighted MRI of a diffusable tracer: Standardized quantities and symbols. J Magn Reson Imaging 1999;10:223-32. (Pubitemid 29463104)
19. Hittmair K, Gomiscek G, Langenberger K, Recht M, Imhof H, Kramer J. Method for the quantitative assessment of contrast agent uptake in dynamic contrast-enhanced MRI. Magn Reson Med 1994;31:567-71. (Pubitemid 24129954)
20. Mayr NA, Yuh WT, Arnholt JC, Ehrhardt JC, Sorosky JI, Magnotta VA, et al. Pixel analysis of MR perfusion imaging in predicting radiation therapy outcome in cervical cancer. J Magn Reson Imaging 2000;12:1027-33.
21. Loncaster JA, Carrington BM, Sykes JR, Jones AP, Todd SM, Cooper R, et al. Prediction of radiotherapy outcome using dynamic contrast-enhanced MRI of carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2002;54:759-67.
22. Morgan B, Utting JF, Higginson A, Thomas AL, Steward WP, Horsfield MA. A simple, reproducible method for monitoring the treatment of tumours using dynamic contrast-enhanced MR imaging. Br J Cancer 2006;94:1420-7. (Pubitemid 43772276)
23. Nielsen T, Murata R, Maxwell RJ, Stø d kilde-Jør gensen H, Østergaard L, Horsman MR. Preclinical studies to predict efficacy of vascular changes induced by combretastatin A-4 disodium phosphate in patients. Int J Radiat Oncol Biol Phys 2008;70:859-66.
24. Viertl D, Delaloye AB, Lanz B, Poitry-Yamate C, Gruetter R, Mlynarik V, et al. Increase of 18 F.FLT tumor uptake in vivo mediated by FdUrd: Toward improving cell proliferation positron emission tomography. Mol Imaging Biol 2010, June 16 Epub ahead of print.. DOI: 10.1007/s11307- 010-0368-z.
25. Mima K, Hirota M, Abe S, Iwatsuki M, Imamura H, Tsuruzoe S, et al. Small solid pseudopapillary tumor of the pancreas in a 32-year-old man: Report of a case. Surg Today 2010;40:772-6.
26. DeJordy JO, Bendel P, Horowitz A, Salomon Y, Degani H. Correlation of MR imaging and histologic findings in mouse melanoma. J Magn Reson Imaging 1992;2:695-700.
27. Lyng H, Haraldseth O, Rofstad EK. Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging. Magn Reson Med 2000;43:828-36. (Pubitemid 30387603)